Epitel is a medical technology company that develops wearable EEG devices and software for neurological monitoring and data analysis.
Epitel has raised $26.0M in total funding. The most recent round was Series B. The last funding was announced in July 2026.
Epitel's investors include Genoa Ventures, National Institutes of Health, Wavemaker 360, OSF Ventures, Catalyst Health Ventures.
Epitel is headquartered in Salt Lake City, United States.
Epitel is a medical technology company that develops wearable EEG devices and software for neurological monitoring and data analysis.
Epitel is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Epitel — Funding & Investors." VCBacked, July 28, 2026, https://www.vcbacked.co/company/epitel. Accessed September 8, 2026.
VCBacked. (2026). Epitel — Funding & Investors. Retrieved September 8, 2026, from https://www.vcbacked.co/company/epitel
{{cite web |title=Epitel — Funding & Investors |url=https://www.vcbacked.co/company/epitel |website=VCBacked |access-date=September 8, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated